VHL inhibits the induction of various target molecules of HIFs, such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF), by forming a complex (BVC) with elongin B/C and Cullin2, thereby exerting its tumor suppressor effect16. The gene discussed is VEGFA; the disease is neoplasm.